◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

CARGO THERAPEUTICS, INC.

CIK: 1966494 SIC: 2836
-
Revenue
$-221.78M
Net Income
-
Gross Margin
-
Op. Margin
$-297.82M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 2 of 2 annual reports available (2023 - 2024)
Breakdown TTM
(Jun 30, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
Operating Expenses $238.57M $187.37M $96.71M
Research & Development $113.58M $143.40M $75.79M
Operating Income $-238.57M $-187.37M $-96.71M
Interest Expense - - $1.60M
Interest Income $17.28M $20.06M $4.87M
Other Income/Expense $-486.00K $-195.00K $4.81M
Net Income $-221.78M $-167.50M $-98.15M
Basic EPS -4.64 -3.72 -16.53
Diluted EPS -4.64 -3.72 -16.53
Basic Shares Outstanding 48.1M 45.0M 5.9M
Diluted Shares Outstanding 48.1M 45.0M 5.9M
Breakdown FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
Cash & Cash Equivalents $64.38M $405.73M
Short-term Investments $275.32M -
Other Current Assets $5.31M $3.75M
Total Current Assets $345.01M $409.48M
Property Plant & Equipment $11.29M $10.38M
Long-term Investments $28.39M -
Other Non-current Assets $5.31M $4.39M
Total Assets $414.05M $453.04M
Accounts Payable $2.44M $5.01M
Total Current Liabilities $25.03M $21.16M
Other Non-current Liabilities - $225.00K
Total Liabilities $53.83M $47.65M
Common Stock $46.00K $41.00K
Retained Earnings $-312.65M $-145.15M
Total Stockholders Equity $360.23M $405.39M
Total Liabilities & Equity $414.05M $453.04M
Breakdown TTM
(Jun 30, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
Net Income $-386.44M $-167.50M $-98.15M
Stock-based Compensation $36.98M $17.97M $3.33M
Change in Payables $6.03M $-2.10M $757.00K
Operating Cash Flow $-292.51M $-139.74M $-81.16M
Capital Expenditure $5.31M $4.45M $8.28M
Purchases of Investments $768.25M $604.87M -
Investing Cash Flow $-111.64M $-305.08M $-8.99M
Financing Cash Flow $103.55M $103.47M $494.58M
Net Change in Cash $-300.60M $-341.35M $404.43M
SEC Filing Format - Data shown as it appears in the Q2 2025 (10-Q) filing Period ended: Jun 30, 2025
Condensed Consolidated Statements of Operations
Description Jun 30, 2025 Jun 30, 2025
Current Prior Year Current YTD Prior Year YTD
Operating Expenses $52.90M - $141.32M -
Research & Development $7.51M - $38.15M -
Operating Income $-52.90M - $-141.32M -
Interest Income $3.27M - $7.21M -
Other Income/Expense $-307.00K - $-318.00K -
Net Income $-49.94M $-35.81M $-134.44M -
Basic EPS -1.04 - -2.80 -
Diluted EPS -1.04 - -2.80 -
Basic Shares Outstanding $48.13M - $47.99M -
Diluted Shares Outstanding $48.13M - $47.99M -
Condensed Consolidated Balance Sheets
Description Jun 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $107.75M $64.38M
Short-term Investments $144.82M $275.32M
Other Current Assets $4.99M $5.31M
Total Current Assets $258.61M $345.01M
Property Plant & Equipment - $11.29M
Long-term Investments - $28.39M
Other Non-current Assets - $5.31M
Total Assets $258.61M $414.05M
Accounts Payable $8.67M $2.44M
Total Current Liabilities $20.91M $25.03M
Total Liabilities $20.91M $53.83M
Common Stock $46.00K $46.00K
Retained Earnings $-447.08M $-312.65M
Total Stockholders Equity $237.70M $360.23M
Total Liabilities & Equity $258.61M $414.05M
Condensed Consolidated Statements of Cash Flows
Description Jun 30, 2025 Jun 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-49.94M $-35.81M $-134.44M -
Stock-based Compensation - - $12.13M -
Change in Payables - - $6.53M -
Operating Cash Flow - - $-115.08M -
Capital Expenditure - - $481.00K -
Purchases of Investments - - $81.69M -
Investing Cash Flow - - $158.40M -
Financing Cash Flow - - $43.00K -
Net Change in Cash - - $43.37M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading news...
TRENDING
Loading...